Telomerase: a nexus between cancer nanotherapy and circadian rhythm-Reference-Cited by-同舟云学术

登录注册会员服务联系我们

Telomerase: a nexus between cancer nanotherapy and circadian rhythm

Published:2024 Issue:9 Volume:12 Page:2259-2281
ISSN:2047-4830
Container-title:Biomaterials Science
language:en
Short-container-title:Biomater. Sci.

Author:

Ghosh Pramit Kumar¹^ORCID,Rao Maddila Jagapathi¹,Putta Chandra Lekha¹,Ray Sandipan²^ORCID,Rengan Aravind Kumar¹^ORCID

Affiliation:

1. Department of Biomedical Engineering, Indian Institute of Technology (IIT), Hyderabad, India

2. Department of Biotechnology, Indian Institute of Technology (IIT), Hyderabad, India

Abstract

The use of nanoparticles for identifying and suppressing telomerase presents promising opportunities for anticancer strategies, particularly in relation to circadian regulation.

Funder

Science and Engineering Research Board

University Grants Commission

Ministry of Human Resource Development

Publisher

Royal Society of Chemistry (RSC)

Link

http://pubs.rsc.org/en/content/articlepdf/2024/BM/D4BM00024B

Reference141 articles.

1. GLOBOCAN 2020 Report on Global Cancer Burden: Challenges and Opportunities for Surgical Oncologists

2. Global Cancer Statistics 2020: GLOBOCAN Estimates of Incidence and Mortality Worldwide for 36 Cancers in 185 Countries

3. Frequency of TERT promoter mutations in human cancers

4. The human telomere terminal transferase enzyme is a ribonucleoprotein that synthesizes TTAGGG repeats

同舟云学术

1.学者识别学者识别

2.学术分析学术分析

3.人才评估人才评估

"同舟云学术"是以全球学者为主线，采集、加工和组织学术论文而形成的新型学术文献查询和分析系统，可以对全球学者进行文献检索和人才价值评估。用户可以通过关注某些学科领域的顶尖人物而持续追踪该领域的学科进展和研究前沿。经过近期的数据扩容，当前同舟云学术共收录了国内外主流学术期刊6万余种，收集的期刊论文及会议论文总量共计约1.5亿篇，并以每天添加12000余篇中外论文的速度递增。我们也可以为用户提供个性化、定制化的学者数据。欢迎来电咨询！咨询电话：010-8811{复制后删除}0370

www.globalauthorid.com

TOP